Pharmaceuticals News and Research

RSS

$2.4 million NIH grant to study TV ads and smoking behaviors

The University of Illinois at Chicago has received a $2.4 million grant from the National Institutes of Health to investigate the impact of anti-smoking television advertising on youth, young adult and adult smoking behaviors.

23 Jan 2008

Popular sleeping pill Stilnox in danger of being classed with morphine, narcotics and amphetamines

A popular sleeping pill that has reportedly triggered bizarre side-effects in some people, could be placed by Australian drug regulators into the same class as morphine, narcotics and amphetamines.

22 Jan 2008

AIDS Healthcare Foundation criticizes Etravirine's pricing

AIDS Healthcare Foundation (AHF) has urged Tibotec Pharmaceuticals Ltd., a division of Johnson & Johnson, to reconsider and reduce its steep price for its newest AIDS drug, etravirine (TMC 125), a non-nucleoside reverse transcriptase inhibitor, (NNRTI), which received Food and Drug Administration (FDA) approval on Friday after a fast track or 'priority review' and approval process granted to companies for medications and therapies intended to treat life-threatening illnesses such as AIDS.

22 Jan 2008

Extra warning of blood clot risk with contraceptive skin patch

Drug regulators in the United States have granted approval for an additional warning to be added to the label of a popular contraceptive patch.

21 Jan 2008

Label change for Ortho Evra Contraceptive Transdermal Patch

The U.S. Food and Drug Administration (FDA) has approved additional changes to the Ortho Evra Contraceptive Transdermal (Skin) Patch label to include the results of a new epidemiology study that found that users of the birth control patch were at higher risk of developing serious blood clots, also known as venous thromboembolism (VTE), than women using birth control pills.

21 Jan 2008

National High Magnetic Field Lab receives $2 million to tackle tuberculosis

About 5,000 people around the world die from tuberculosis every day, but no effective new drugs have been developed to combat it in 40 years.

18 Jan 2008

Nanobac announces Baylor initial results for nanoparticle and gall stone formation study

Nanobac Pharmaceuticals Inc has announced that scientists at the Baylor College of Medicine, working under a collaborative agreement with Nanobac, have cited evidence showing the presence of calcifying nanoparticles (CNPs) in surgically resected gallbladders with cholelithiasis (Gall Stones).

15 Jan 2008

FDA extends review of Genasense NDA appeal in chronic lymphocytic leukemia

Genta Incorporated has announced that the Food and Drug Administration (FDA) has extended its review of Genta's appeal of the non- approvable decision for a New Drug Application (NDA) that proposed the use of Genasense (oblimersen sodium injection) plus chemotherapy in patients with relapsed or refractory chronic lymphocytic leukemia.

15 Jan 2008

Caraco Pharmaceutical Labs announces FDA approval to market generic Metaglip

Caraco Pharmaceutical Laboratories, Ltd., has announced that the US Food and Drug Administration (FDA) has granted final approval for the Company's Abbreviated New Drug Application (ANDA) for Glipizide/Metformin Hydrochloride Tablets, 2.5/250 mg, 2.5/500 mg and 5/500 mg (Glipizide/Metformin HCl).

15 Jan 2008

Minister predicts role for stem cell biologists in re-shaped pharmaceutical industry

Stem cell research should have a bright future and could play an important role in tomorrow's pharmaceutical industry, Spain's Minister for Health told an international conference of stem cell biologists on January 11.

15 Jan 2008

Chewing too much gum linked to excessive weight loss

German scientists have revealed a link between chewing too much gum and excessive weight loss.

14 Jan 2008

Memantine and Alzheimer's

In a study published this month in the Journal of Alzheimer's Disease, researchers from the University of Aberdeen report that the drug memantine, used for the treatment of Alzheimer's disease and praised as "the first and only representative of a new class of Alzheimer drugs" works in fact similar to other existing compounds, and is beneficial only in a narrow concentration range.

14 Jan 2008

Barr Pharmaceuticals confirms patent challenge of Namenda tablets

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed by Forest Laboratories, Inc. in connection with its Namenda (memantine hydrochloride) tablets, 5mg and 10mg.

14 Jan 2008

The relationship between periodontal disease and systemic health

Physicians and dentists will have a unique opportunity to discuss the link between oral health and overall health at a program on January 18 at the New York Academy of Sciences (NYAS).

11 Jan 2008

Review of Memantine for Alzheimer's

11 Jan 2008

Morphotek announces agreement for development of antibodies to treat prostate cancer

Morphotek, Inc., a subsidiary of Eisai Co., Ltd., has announced that it has signed a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) for the development of therapeutic antibodies to a cancer-associated protein identified by NCI researchers.

10 Jan 2008

Barr Pharmaceuticals confirms Eloxatin injectable patent challenge

Barr Pharmaceuticals, Inc. has announced that its subsidiary, Barr Laboratories, has initiated a challenge of the patents listed by Sanofi-Aventis U.S. LLC in connection with its Eloxatin(R) (Oxaliplatin Aqueous Solution), 5mg/mL Injectable.

10 Jan 2008

NicOx extends ophthalmology agreement with Pfizer

NicOx S.A. has announced it has signed an extension of its March 2006 collaboration agreement, which grants Pfizer Inc the exclusive right to apply its proprietary nitric oxide-donating technology to drug discovery research in the field of ophthalmology.

9 Jan 2008

Nastech receives U.S. patent for methods for identifying cell-specific targeting peptides

Nastech Pharmaceutical Company Inc. has announced that the U.S. Patent and Trademark Office (USPTO) has issued a Notice of Allowance for U.S. patent application No. 10/976,942, entitled "Phage Displayed Trp Cage Ligands".

9 Jan 2008

Heavy smokers most likely to turn to treatment

Smokers who seek out treatment to give up the habit are less successful at quitting than smokers who try to snuff the habit without help, according to a new study.

9 Jan 2008